189 related articles for article (PubMed ID: 17662122)
1. Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T.
Sjøbakk TE; Johansen R; Bathen TF; Sonnewald U; Kvistad KA; Lundgren S; Gribbestad IS
BMC Cancer; 2007 Jul; 7():141. PubMed ID: 17662122
[TBL] [Abstract][Full Text] [Related]
2. Characterization of brain metastases using high-resolution magic angle spinning MRS.
Sjøbakk TE; Johansen R; Bathen TF; Sonnewald U; Juul R; Torp SH; Lundgren S; Gribbestad IS
NMR Biomed; 2008 Feb; 21(2):175-85. PubMed ID: 17542042
[TBL] [Abstract][Full Text] [Related]
3. Brain metastases in breast cancer: prognostic factors and management.
Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
[TBL] [Abstract][Full Text] [Related]
4. MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status.
Bathen TF; Jensen LR; Sitter B; Fjösne HE; Halgunset J; Axelson DE; Gribbestad IS; Lundgren S
Breast Cancer Res Treat; 2007 Aug; 104(2):181-9. PubMed ID: 17061040
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 1H-MRS-detected metabolic characteristics in single metastatic brain tumors of different origin.
Chernov MF; Ono Y; Kubo O; Hori T
Brain Tumor Pathol; 2006 Apr; 23(1):35-40. PubMed ID: 18095117
[TBL] [Abstract][Full Text] [Related]
6. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.
Barnholtz-Sloan JS; Sloan AE; Davis FG; Vigneau FD; Lai P; Sawaya RE
J Clin Oncol; 2004 Jul; 22(14):2865-72. PubMed ID: 15254054
[TBL] [Abstract][Full Text] [Related]
7. [Monitoring of irradiated brain metastases using MR perfusion imaging and 1H MR spectroscopy].
Weber MA; Lichy MP; Thilmann C; Günther M; Bachert P; Maudsley AA; Delorme S; Schad LR; Debus J; Schlemmer HP
Radiologe; 2003 May; 43(5):388-95. PubMed ID: 12764588
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of the radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases: importance of multi-voxel proton MRS.
Chernov M; Hayashi M; Izawa M; Ochiai T; Usukura M; Abe K; Ono Y; Muragaki Y; Kubo O; Hori T; Takakura K
Minim Invasive Neurosurg; 2005 Aug; 48(4):228-34. PubMed ID: 16172969
[TBL] [Abstract][Full Text] [Related]
9. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
Gajewicz W; Papierz W; Szymczak W; Goraj B
Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
[TBL] [Abstract][Full Text] [Related]
10. Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases.
Chernov MF; Hayashi M; Izawa M; Usukura M; Yoshida S; Ono Y; Muragaki Y; Kubo O; Hori T; Takakura K
Brain Tumor Pathol; 2006 Apr; 23(1):19-27. PubMed ID: 18095115
[TBL] [Abstract][Full Text] [Related]
11. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
12. Metabolic characteristics of intracranial metastases, detected by single-voxel proton magnetic resonance spectroscopy, are seemingly not predictive for tumor response to gamma knife radiosurgery.
Chernov M; Hayashi M; Izawa M; Nakaya K; Ono Y; Usukura M; Yoshida S; Kato K; Muragaki Y; Nakamura R; Iseki H; Hori T; Takakura K
Minim Invasive Neurosurg; 2007 Aug; 50(4):233-8. PubMed ID: 17948183
[TBL] [Abstract][Full Text] [Related]
13. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different treatment approaches for one to two brain metastases in elderly patients.
Rades D; Pluemer A; Veninga T; Schild SE
Strahlenther Onkol; 2008 Nov; 184(11):565-71. PubMed ID: 19016014
[TBL] [Abstract][Full Text] [Related]
15. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.
Sitter B; Bathen TF; Singstad TE; Fjøsne HE; Lundgren S; Halgunset J; Gribbestad IS
NMR Biomed; 2010 May; 23(4):424-31. PubMed ID: 20101607
[TBL] [Abstract][Full Text] [Related]
16. Disease presentation and treatment outcome in very young patients with brain metastases from lung cancer.
Nieder C; Thamm R; Astner ST; Molls M
Onkologie; 2008 Jun; 31(6):305-8. PubMed ID: 18547970
[TBL] [Abstract][Full Text] [Related]
17. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer metastatic to the brain: time trends in presentation and outcome.
Nieder C; Pawinski A; Balteskard L
Oncology; 2009; 76(5):369-74. PubMed ID: 19321946
[TBL] [Abstract][Full Text] [Related]
19. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
Sitter B; Lundgren S; Bathen TF; Halgunset J; Fjosne HE; Gribbestad IS
NMR Biomed; 2006 Feb; 19(1):30-40. PubMed ID: 16229059
[TBL] [Abstract][Full Text] [Related]
20. Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics.
Giskeødegård GF; Grinde MT; Sitter B; Axelson DE; Lundgren S; Fjøsne HE; Dahl S; Gribbestad IS; Bathen TF
J Proteome Res; 2010 Feb; 9(2):972-9. PubMed ID: 19994911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
